The following has been passed on by a member with details of the event referred to in the quotes:
The Science of COVID | Royal Society (30-31 March 2022)
https://royalsociety.org/science-events-and-lectures/2022/03/tof-covid/
The Science of COVID | Royal Society (30-31 March)
https://royalsociety.org/science-events-and-lectures/2022/03/tof-covid/
1 talk on 'Long Covid':
Long Covid: A long lasting legacy of the pandemic?
Dr Nathalie MacDermott, King’s College London
(Clinical lecturer in paediatrics, paediatric infectious diseases and Immunology and bone marrow transplant )
Program PDF here:
https://royalsociety.org/-/media/ev...a=en-GB&hash=D7590FE9FD1F76B4ABA69C27C1E1CC59
From biography / Abstract:
Dr Nathalie MacDermott, King’s College London
Biography: Dr MacDermott is an academic clinical lecturer at King’s College London funded by the NIHR. She works clinically as a paediatric infectious diseases doctor, but her research background is in epidemic and pandemic diseases. Her PhD, awarded by Imperial College London, investigated genetic susceptibility to outcome from Ebola virus disease in Sierra Leone [....] including post-Ebola conditions in Ebola survivors.
She is currently investigating post COVID-19 problems (‘Long Covid’) in children utilising multidisciplinary clinical assessment, magnetic resonance imaging, immune phenotyping and, in the longer term, genetic analysis to understand the different phenotypes and pathogeneses of the varied presentations of this condition. Dr MacDermott also suffers from a Post COVID condition following becoming infected while working on the front line.
Abstract:
Long Covid: A long lasting legacy of the pandemic?
Long COVID covers a multitude of persistent symptoms and conditions which follow on from acute COVID-19, whether severe or mild. The most recent report from the Office for National Statistics (ONS) estimates that 1.5 million people (2.4% of the UK population) were experiencing self-reported long COVID as of 31st January 20221, of which 45% had symptoms for longer than a year. The middle-aged adult population is most affected, particularly females.
Reports from employers suggest a quarter put long COVID in the top three reasons for long term sickness absence. Similarly, there has been a 20% increase in applications for Personal Independence Payments in the last year. Long COVID affects approximately 2% of children and young people following acute COVID19, impactingtheir education, future earning potential and resulting in parental work absence. The economic impact of long-term sickness among the UK working population due to long COVID remains unclear but is likely substantial.
Why has long COVID not been considered when deciding public health measures to mitigate spread of SARS-COV2? The long-term morbidity and disability of the UK population must be given due consideration, it will be a long-lasting legacy of the pandemic.
But there's also:
Lessons learned from the Pandemic for science communications in an
emergency
Fiona Fox OBE, Science Media Centre
(abstract see progam link above)